Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.

Saved in:
Bibliographic Details
Title: Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.
Authors: Liao Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Yang R; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Wang B; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Ruan Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Cui L; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Yang J; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Yu X; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Han S; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Yao Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Luan X; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Li Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Shi M; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China., Li S; State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, Harbin, China. shuijie.li@hrbmu.edu.cn.; Heilongjiang Province Key Laboratory of Research on Molecular Targeted Anti-Tumor Drugs, Harbin, China. shuijie.li@hrbmu.edu.cn., Liu C; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China. liuchao@hrbmu.edu.cn.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China. liuchao@hrbmu.edu.cn.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China. liuchao@hrbmu.edu.cn., Zhang Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China. yanqiaozhang@ems.hrbmu.edu.cn.; Key Laboratory of Tumor Immunology in Heilongjiang, Harbin, China. yanqiaozhang@ems.hrbmu.edu.cn.; Clinical Research Center for Colorectal Cancer in Heilongjiang, Harbin, China. yanqiaozhang@ems.hrbmu.edu.cn.
Source: Oncogene [Oncogene] 2025 Apr; Vol. 44 (14), pp. 944-957. Date of Electronic Publication: 2024 Dec 26.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5594
DOI:10.1038/s41388-024-03255-2